VIVUS LLC: Obesity trials
The registry lists 11 Obesity studies with VIVUS LLC as lead sponsor. 0 are open to participants now and 9 have results posted.
Phase 1 3Phase 2 2Phase 3 4Phase 4 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese SubjectsCompletedNCT05215418Phase 4Results posted
- A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With ObesityCompletedNCT03922945Phase 4Results posted
- Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy SubjectsCompletedNCT02229214Phase 4Results posted
- A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.CompletedNCT00806260Phase 2Results posted
- A Safety and Efficacy Study of VI-0521 to Evaluate the Long Term Treatment of Obesity in Adults With Obesity-Related Co-Morbid Conditions. An Extension Study of Protocol OB-303 (NCT00553787)CompletedNCT00796367Phase 3Results posted
- A Study of VI-0521 for the Treatment of Obstructive Sleep Apnea / Hypopnea Syndrome in Obese AdultsCompletedNCT00745251Phase 1/2Results posted
- A Study Comparing Multiple Doses of VI-0521 With Placebo and Their Single-agent Constituents for Treatment of Obesity in AdultsCompletedNCT00563368Phase 3Results posted
- Study of VI-0521 Compared to Placebo in Treatment of Obesity in AdultsCompletedNCT00554216Phase 3Results posted
- Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid ConditionsCompletedNCT00553787Phase 3Results posted
- A Drug Interaction Study of VI-0521 With Metformin, Sitagliptan and Probenecid in Healthy Subjects.CompletedNCT00842400Phase 1
- Pharmacokinetic Comparison of Multiple Formulations of Topiramate and Phentermine in Obese AdultsCompletedNCT00518466Phase 1